Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies

NCT03182777 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2024-04-09

No results posted yet for this study

Summary

Patients with cardiac channelopathies needing restorative dental treatment will be included in two sessions of the study, using local dental anesthetic: lidocaine 2% with epinephrine and lidocaine 2% without vasoconstrictor. The safety of the use of two cartridges (3.6 mL) will be evaluated. The patients will be their own control and will be assessed by Holter monitoring for 28 hours, blood pressure measurement and anxiety measuring.

Conditions

  • Channelopathies
  • Brugada Syndrome
  • Long QT Syndrome
  • Ventricular, Tachycardia

Interventions

PROCEDURE

Dental restorative procedure

Infiltration of two cartridges (3.6 mL) of local anesthetics with 2% lidocaine with or without epinephrine 1:100,000, in two sessions with an interval of seven days between them, in oral mucosa in patients with cardiac channelopathies.

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV
  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Itamara LI Neves, PhD · Instituto do Coração do HCFMUSP

  • Ana CG Oliveira, S · Instituto do Coração do HCFMUSP

  • Ricardo S Neves, PhD · Instituto do Coração do HCFMUSP

  • Luciana Sacilotto, S · Instituto do Coração do HCFMUSP

  • Francisco CC Darrieux, PhD · Instituto do Coração do HCFMUSP

  • Maurício I Scanavacca, PhD · Instituto do Coração do HCFMUSP

  • Denise Hachul, PhD · Instituto do Coração do HCFMUSP

  • Cesar J Gruppi, PhD · Instituto do Coração do HCFMUSP

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03182777 on ClinicalTrials.gov